Cargando…
Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
BACKGROUND: We hypothesized that the total volume of metastases at initial oligometastatic (OM) presentation to stereotactic body radiation therapy (SBRT) is an important prognostic factor that can refine the definition of OM disease. METHODS: Patients with extracranial oligometastatic cancer (≤5 le...
Autores principales: | Cao, Yilin, Chen, Hanbo, Sahgal, Arjun, Erler, Darby, Badellino, Serena, Biswas, Tithi, Dagan, Roi, Foote, Matthew C., Louie, Alexander V., Poon, Ian, Ricardi, Umberto, Redmond, Kristin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607244/ https://www.ncbi.nlm.nih.gov/pubmed/34668651 http://dx.doi.org/10.1002/cam4.4332 |
Ejemplares similares
-
Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis
por: Chen, Xuguang, et al.
Publicado: (2021) -
Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020) -
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study
por: Baydoun, A., et al.
Publicado: (2021) -
Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach
por: Ricardi, Umberto, et al.
Publicado: (2016) -
Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)